Another major player in immune tolerance is IDO (indoleamine 2,2 dioxygenase), an enzyme of the kynurenine pathway [110], which we recently identified as a molecular target downstream from PrPC signalling in colorectal cancer [26]. Here, PRNP is linked to colorectal cancer.